Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

Clinical trial NCT03515252 · COMPLETED

Trial details

NCT number: NCT03515252
Sponsor: Ivy Life Sciences, Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

NSCLC Stage IIIB NSCLC Stage IV Hepatocellular Carcinoma by BCLC Stage Lung Cancer Liver Cancer

Start date: 2005-04-26
Primary completion: 2006-11-02
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.